Probiotics in Human Immunodeficiency Virus Infection: A Systematic Review and Evidence Synthesis of Benefits and Risks
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
People living with human immunodeficiency virus frequently use dietary supplements, including probiotics, but concern exists about ingesting live organisms. We performed a systematic review of the benefits of probiotics and a meta-analysis of sepsis risk. We undertook a protocol-driven, comprehensive review to identify all relevant studies, assess their quality, and summarize the evidence. Of 2068 references, 27 were analyzed. The data suggest possible benefits for CD4 count, recurrence or management of bacterial vaginosis, and diarrhea management. We examined randomized, controlled studies explicitly assessing sepsis in any patient population, and we found zero cases of supplement-associated bacteremia or fungemia in 39 randomized controlled trials comprising 9402 subjects. The estimated number needed to harm is 7369 in Bayesian approach (95% credible interval: 1689, ∞), which should reassure clinicians. No or mild adverse effects were reported. Longer duration studies investigating different individual and mixed strains for plausible indications are needed to establish best practices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Fu, R., Gartlehner, G., Grant, M., Shamliyan, T., Sedrakyan, A., Wilt, T. J., Griffith, L., Oremus, M., Raina, P., Ismaila, A., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.08.010 · Cited by 730
Snydman, D. R. (2008) · Clinical Infectious Diseases · doi:10.1086/523331 · Cited by 336
Li, B.-Z., Threapleton, D. E., Wang, J.-Y., Xu, J.-M., Yuan, J.-Q., Zhang, C., Li, P., Ye, Q.-L., Guo, B., Mao, C., et al. (2015) · BMJ · doi:10.1136/bmj.h4052 · Cited by 176
Effect of 25 weeks probiotic supplementation on immune function of HIV patients
Hummelen, R., Changalucha, J., Butamanya, N. L., Koyama, T. E., Cook, A., Habbema, J. D. F., & Reid, G. (2011) · Gut Microbes · doi:10.4161/gmic.2.2.15787 · Cited by 117
McFarland, L. (2015) · Antibiotics · doi:10.3390/antibiotics4020160 · Cited by 109 · cited 1×
“Evidence is fairly robust for the use of probiotics for primary prevention, with weaker evidence as secondary prophylaxis for Clostridium difficile infections [9].”
BackgroundSalminen, M. K., Tynkkynen, S., Rautelin, H., Poussa, T., Saxelin, M., Ristola, M., Valtonen, V., & Järvinen, A. (2004) · HIV Clinical Trials · doi:10.1310/6f83-n39q-9ppp-lmvv · Cited by 103 · cited 8×
“In a 2-week crossover trial among 17 patients, no impact on CD4 was seen [35].”
BackgroundInfluentialProbiotics: potential to prevent HIV and sexually transmitted infections in women
Bolton, M., van der Straten, A., & Cohen, C. R. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31815b017a · Cited by 67
Cited by
Probiotic supplements might not be universally-effective and safe: A review
Kothari, D., Patel, S., & Kim, S.-K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.104 · Cited by 445
Reappraisal of probiotics’ safety in human
Sotoudegan, F., Daniali, M., Hassani, S., Nikfar, S., & Abdollahi, M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.032 · Cited by 154
Microbiota and Probiotics in Health and HIV Infection
D’Angelo, C., Reale, M., & Costantini, E. (2017) · Nutrients · doi:10.3390/nu9060615 · Cited by 97
Darb Emamie, A., Rajabpour, M., Ghanavati, R., Asadolahi, P., Farzi, S., Sobouti, B., & Darbandi, A. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14907 · Cited by 57
Zhang, X.-L., Chen, M.-H., Geng, S.-T., Yu, J., Kuang, Y.-Q., Luo, H.-Y., & Wang, K.-H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.570520 · Cited by 25
“Fortunately, increasing scientific evidence supports the view that probiotic supplements may be therapeutically helpful in the prevention of diarrhea in HIVpositive patients and the reconstitution of a normal gut microbiome (Anukam et al., 2008; Cunningham-Rundles et al., 2000; Irvine et al., 2010; Carter et al., 2016…”
Background
Metadata
- Authors
- Carter, G. M., Esmaeili, A., Shah, H., Indyk, D., Johnson, M., Andreae, M., & Sacks, H. S.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016
- Volume
- 3
- Issue
- 4
- Pages
- ofw164-ofw164
- ISSN
- 2328-8957 (ISSN-L)
- OpenAlex
- W2531707166
- Cited by
- 47
- References
- 8
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.